Cargando…
Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil
Effective treatment of tuberculosis (TB) remains a serious public health problem in many countries, including Brazil, especially when considering drug-resistant disease. Xpert MTB/RIF has been implemented in many countries to reduce the time to TB diagnosis and to rapidly detect rifampicin resistanc...
Autores principales: | Feliciano, Cinara Silva, Menon, Lucas José Bazzo, Anselmo, Livia Maria Pala, Dippenaar, Anzaan, Warren, Robin Mark, Silva, Wilson Araújo, Bollela, Valdes Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680070/ https://www.ncbi.nlm.nih.gov/pubmed/31404338 http://dx.doi.org/10.1183/23120541.00043-2019 |
Ejemplares similares
-
Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019) -
Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
por: Kohli, Mikashmi, et al.
Publicado: (2021) -
Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children
por: Kay, Alexander W, et al.
Publicado: (2020) -
An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
por: Cayci, Yeliz Tanriverdi, et al.
Publicado: (2017) -
Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
por: Kohli, Mikashmi, et al.
Publicado: (2018)